Non-invasive analysis and controlled dosage transdermal active patch

• US 20090118710A1
• Filed: 12/15/2008
• Published: 05/07/2009
• Est. Priority Date: 04/13/2004
• Status: Abandoned Application

• Current Assignee: Robert N. Kortzeborn
• Original Assignee: Robert N. Kortzeborn
• Inventors: Kortzeborn, Robert N.
• Application Number:
  US12/316,633
• Publication Number:
  US 20090118710A1
• Time in Patent Office: Days
• US Class Current: 604/890.100
• CPC Class Codes: A61N 1/303 Constructional details electrodes for external use A61N1/0428

Abstract

A programmable transdermal patch non-invasively delivers pharmaceuticals or other bio-active agents through the skin of a living body. The patch contains one or more agent storage pads and one or more active drivers that apply an electric current to the skin or produce ultrasound to drive the agent into the skin. A digital data processor controls the drivers to match administration of the agents to the needs of the body. The patch may contain a sensor, coupled to the data processor, for monitoring the concentration of a substance in the body in order to vary dosage of a therapeutic agent. A radio contained in the patch enables control by medical personnel from a remote location and/or transmission of sensor data to the remote location. The pads, drivers, sensor, data processor, radio and a battery are all contained within a unitary patch and need no physical connection to external devices.

Claims

1. A transdermal patch for programmed delivery of a bio-active agent into the skin of a living body which patch is fastenable to a surface of the skin, the patch containing at least one agent storage pad positioned to dispense agent into the skin and containing electrically operated driver means for causing delivery of the stored agent from the storage pad into the skin and containing a battery for supplying electrical current to skin contact electrodes of the driver means, further including:

a programmable digital data processor controlling dispensing of said agent by said reservoir pad and driver means;

said data processor programmed to deliver repetitive doses of said agent at a repetition rate which corresponds to the rate at which the concentration of said agent in the body diminishes to a particular value.

2. The transdermal patch for programmed delivery of a bio-active agent of claim 1, wherein each of said repetitive doses is administered for a time period T given by the equation:

T=(t_on)×

(1/n);

where (t_on)=the period of time that the driver electrodes are energized;

(1/n)=a fraction of the initial concentration by which said concentration of said agent is to be allowed to diminish before the next repetitive dose is administered.

3. The transdermal patch for programmed delivery of a bio-active agent of claim 2, wherein n=2 and said expression (1/n) is the half life of the initial dosage of said agent in the body.

4. The transdermal patch for programmed delivery of a bio-active agent of claim 2, wherein said repetitive doses includes an initial dosage N to achieve an initial concentration of said agent in the body, said driver means operating at a voltage V for a time period (t_on) to deliver said initial dosage N.

5. The transdermal patch for programmed delivery of a bio-active agent of claim 4, wherein n=2 and said expression (1/n) is the half life of said initial dosage N of said agent in the body.

6. A transdermal patch for programmed delivery of a bio-active agent into the skin of a living body which patch is fastenable to a surface of the skin, the patch containing at least one agent storage pad positioned to dispense agent into the skin and containing electrically operated driver means for causing delivery of the stored agent from the storage pad into the skin and containing a battery for supplying electrical current to skin contact electrodes of the driver means, further including:

a programmable digital data processor controlling dispensing of said agent by said reservoir pad and driver means;

said data processor being programmed to vary the dosage of said agent during a period of time to conform to variations of the rate at which the agent is needed by the body during the period of time.

7. The transdermal patch for programmed delivery of a bio-active agent of claim 6, wherein said data processor is programmed to provide an initial dosage N to achieve an initial concentration of said agent in the body, said driver means operating at a voltage V for a time period (t_on) to deliver said initial dosage N.

8. The transdermal patch for programmed delivery of a bio-active agent of claim 7, wherein said data processor is programmed to provide repetitive doses administered for a time period T given by the equation:

T=(t_on)×

(1/n);

where (t_on)=the period of time that the driver electrodes are energized;

(1/n)=a fraction of said initial concentration by which said initial concentration of said agent is to be allowed to diminish before the next repetitive dose is administered.

9. The transdermal patch for programmed delivery of a bio-active agent of claim 8, wherein n=2 and said expression (1/n) is the half life of said initial dosage N of said agent in the body.

10. The transdermal patch for programmed delivery of a bio-active agent of claim 6, wherein said data processor is programmed to provide repetitive doses administered for a time period T given by the equation:

T=(t_on)×

(1/n);

where (t_on)=the period of time that the driver electrodes are energized;

(1/n)=a fraction of an initial concentration by which said initial concentration of said agent is to be allowed to diminish before the next repetitive dose is administered.